Alafaleq, Munirah
van Haselen, Robert
Ferrari, Francis
Article History
Received: 5 September 2022
Accepted: 7 April 2023
First Online: 27 June 2023
Declarations
:
: The study is conducted according to the French data protection law. No submission to IRB/ethical committee was needed, as the study is out of the scope of the law of Jardé. The study adheres to the tenets of the Declaration of Helsinki. Informed consent obtained from patient for Fig. 3.
: FF is a pioneer of the Femotosecond assisted keratopigmentation procedure. He is a major shareholder in the Neoris company. He is the owner of two related patents:WO2018224791 - DEVICES AND METHOD FOR PREPARING AND CARRYING OUT CORNEAL TATTOOSWO2018122537 - SURGICAL HAND INSTRUMENT. MA and RvH have no interest to disclose.
: Not applicable.